NCT02686580 (FIX-IT1) is a Phase 3 clinical trial of Collagen paste in Anorectal Abscess, sponsored by Royal Devon and Exeter NHS Foundation Trust.

Who is sponsoring NCT02686580?

NCT02686580 is sponsored by Royal Devon and Exeter NHS Foundation Trust.

What drugs are being tested in NCT02686580?

Interventions in NCT02686580: Collagen paste.

What condition does NCT02686580 study?

NCT02686580 studies Anorectal Abscess, Fistula in Ano.

Is NCT02686580 still recruiting?

NCT02686580 is currently terminated. Last updated 12 September 2019.

Last reviewed 2019-09-12 · How we verify

NCT02686580: FIX-IT1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility Study to Assess the Early Use of Porcine Cross-linked Collagen Paste in Cryptoglandular Anorectal Fistulas

Terminated Phase 3 Last updated 12 September 2019

What this trial tests

Phase 3 trial testing Collagen paste in Anorectal Abscess in 2 participants. Terminated before completion.

Timeline

1 February 2016

Primary endpoint
1 October 2018

1 December 2018

Quick facts

Lead sponsor	Royal Devon and Exeter NHS Foundation Trust
Phase	Phase 3
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	2
Start date	1 February 2016
Primary completion	1 October 2018
Estimated completion	1 December 2018

Drugs / interventions tested

Collagen paste — full drug profile →

Conditions studied

Anorectal Abscess — all drugs for Anorectal Abscess →
Fistula in Ano — all drugs for Fistula in Ano →

Sponsor

Royal Devon and Exeter NHS Foundation Trust

Who can join

18 and older, any sex, with Anorectal Abscess or Fistula in Ano. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to assess the effectiveness of porcine cross-linked collagen paste for the treatment of patients with ano-rectal abscess with underlying cryptoglandular fistula in ano.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Royal Devon and Exeter NHS Foundation Trust trials

Trials by the same sponsor.

NCT06685874 — Interstitial Lung Disease Exacerbations Study · active not recruiting
NCT06903780 — Experience of Biologic Treatments for Severe Asthma: a Survey · recruiting
NCT06798779 — Predicting Manifest Astigmatism in Keratoconus Patients. · active not recruiting
NCT06523452 — Laser Speckle Imaging During Breast Reconstruction · NA · recruiting
NCT06099691 — Outcomes That Matter and Questionnaires for Older People With Frailty · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02686580 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Royal Devon and Exeter NHS Foundation Trust
Last refreshed: 12 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02686580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing